Market Place
Sourcing Support
ADvantage Therapeutics Welcomes William as Strategic Advisor
09 Sep 2024 //
GLOBENEWSWIRE
ADvantage Therapeutics Announces Breakthrough In Alzheimer`s Treatment
30 Jul 2024 //
GLOBENEWSWIRE
Dr. Makoto Kuro-o Joins Scientific Advisory Board of ADvantage Therapeutics
05 Feb 2024 //
GLOBENEWSWIRE
ADvantage Has Commenced Enrollment for Its Phase 2b Clinical Trial of AD04
27 Nov 2023 //
GLOBENEWSWIRE
ADvantage Therapeutics Welcomes Esteemed Expert in Alzheimer™s Disease
02 Oct 2023 //
GLOBENEWSWIRE
Klogenix pioneering research finds new home at ADvantage
02 Oct 2023 //
GLOBENEWSWIRE
ADvantage AssistRx Secures Approvals for Clinical Trial of AD04
20 Jun 2023 //
GLOBENEWSWIRE
MHRA Grants ADvantage Therapeutics ILAP Designation for Lead Product AD04
05 Apr 2023 //
GLOBENEWSWIRE
Renowned Public Health Advisor Jim Neill Joins Board of Directors of ADvantage
24 Mar 2023 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.